Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Naoko Yagishita"'
Autor:
Natsuko Yamakawa, Naoko Yagishita, Tomohiro Matsuo, Junji Yamauchi, Takahiko Ueno, Eisuke Inoue, Ayako Takata, Misako Nagasaka, Natsumi Araya, Daisuke Hasegawa, Ariella Coler-Reilly, Shuntaro Tsutsumi, Tomoo Sato, Abelardo Araujo, Jorge Casseb, Eduardo Gotuzzo, Steven Jacobson, Fabiola Martin, Marzia Puccioni-Sohler, Graham P. Taylor, Yoshihisa Yamano, the Japan Clinical Research Group on HAM/TSP
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-11 (2020)
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases
Background Urinary dysfunction is one of the main features of human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). However, a comprehensive assessment of the severity is difficult because a standardized ass
Autor:
Miyuki Kubokawa, Yutaka Suzuki, Tomoo Sato, Toshiki Watanabe, Ayako Arai, Naoko Yagishita, Misako Nagasaka, Yu Uemura, Junji Yamauchi, Yoshihisa Yamano, Eisuke Inoue, Seiichiro Kobayashi, Junya Makiyama, Ayako Takata, Makoto Yamagishi, Daisuke Hasegawa, Natsumi Araya, Kaoru Uchimaru, Ariella Coler-Reilly, Shuntaro Tsutsumi, Yasuhiro Hasegawa
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Significance HTLV-1 manifests many diseases, which cause morbidity and mortality in 5∼10% of infected individuals, including the fatal adult T cell leukemia/lymphoma (ATLL) and debilitating myelopathy (HAM/TSP). However, the rarity of these disease
Autor:
Tomoo Sato, Yoshihisa Yamano, Junji Yamauchi, Ayako Takata, Kenichiro Tanabe, Natsumi Araya, Satoko Aratani, Naoko Yagishita, Naoki Iijima
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-10 (2021)
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-10 (2021)
Background Most patients with human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) develop neurogenic bladder dysfunction. However, longitudinal changes and treatment effects remain poorly understood. This s
Autor:
Shingo Nakahata, Daisuke Sasaki, Shunsuke Yamauchi, Yoshitaka Imaizumi, Makoto Nakashima, Natsumi Araya, Junji Yamauchi, Hiroo Hasegawa, Kenichiro Tanabe, Yasushi Miyazaki, Masao Ogata, Kazuhiro Morishita, Toshiki Watanabe, Masumichi Saito, Tomohiko Tasaka, Haruka Momose, Michikazu Tanio, Naoko Yagishita, Kaoru Uchimaru, Makoto Yamagishi, Ariella Lg Coler-Reilly, Madoka Kuramitsu, Takahiro Matsudaira, Hidekatsu Iha, Tomohiro Okagawa, Naganori Nao, Yoshihisa Yamano, Satoru Konnai, Yusaku Wada, Tomoo Sato, Katsunori Yanagihara
Both natural viral infections and therapeutic interventions using viral vectors pose significant risks of malignant transformation. Monitoring for clonal expansion of infected cells is important for detecting cancer. Here we developed a novel method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bedacfd5a5e40d6fb792ba8374d53aa2
https://doi.org/10.21203/rs.3.rs-526444/v1
https://doi.org/10.21203/rs.3.rs-526444/v1
Publikováno v:
Pharmacologytherapeutics. 218
Human T-cell leukemia virus type I (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a rare inflammatory disease causing unremitting and progressive neurological disorders, such as spastic paraparesis, neurogenic bladder, and s
Autor:
Keiko Tamaki, Tomoo Sato, Jun Tsugawa, Shinsuke Fujioka, Naoko Yagishita, Natsumi Araya, Junji Yamauchi, Ariella L. G. Coler-Reilly, Misako Nagasaka, Yasuhiro Hasegawa, Yoshihisa Yamano, Yoshio Tsuboi
Publikováno v:
Frontiers in Microbiology, Vol 10 (2019)
Frontiers in Microbiology
Frontiers in Microbiology
Human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a debilitating, progressive disease without effective treatment; therefore, development of disease modifying therapy that improves long-term f
Autor:
K. Tamaki, J. Yamauchi, Yoshio Tsuboi, M. Nagasaka, T. Sato, Natsumi Araya, Yoshihisa Yamano, S. Tsutsumi, Shinsuke Fujioka, Jun Tsugawa, Naoko Yagishita
Publikováno v:
Journal of the Neurological Sciences. 405:126-127
Autor:
Yasuhiro Hasegawa, Daisuke Hasegawa, Yoshihisa Yamano, Naoko Yagishita, Junji Yamauchi, Natsumi Araya, Misako Nagasaka, Ayako Takata, Ariella Coler-Reilly, Eisuke Inoue, Tomoo Sato, Shuntaro Tsutsumi
Publikováno v:
Journal of neurology, neurosurgery, and psychiatry. 91(3)
Human T-cell leukaemia virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) damages the spinal cord by chronic inflammation and causes progressive lower limb motor disability.1 Because the associated symptoms gradually p
Autor:
Junji Yamauchi, Ariella Coler-Reilly, Tomoo Sato, Daisuke Hasegawa, Misako Nagasaka, Yoshihisa Yamano, Ayako Takata, Natsumi Araya, Eisuke Inoue, Shuntaro Tsutsumi, Naoko Yagishita
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-13 (2019)
Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-13 (2019)
Background As human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a rare chronic neurological disease, large scale studies to collect continuous clinical data have been difficult to conduct. The
Autor:
Yoshihiko Furusawa, Izumi Yamaguchi, Naoko Yagishita, Kazumasa Tanzawa, Fumihiko Matsuda, Yoshihisa Yamano, RADDAR‐J Research and Development Group
Publikováno v:
Learning Health Systems, Vol 3, Iss 3, Pp n/a-n/a (2019)
Learning Health Systems
Learning Health Systems
Introduction In Japan, there are approximately 300 projects conducting research on rare diseases supported by the Ministry of Health, Labour and Welfare of Japan (MHLW) and the Japan Agency for Medical Research and Development (AMED). Diverse data, i